<?xml version="1.0" encoding="UTF-8"?>
<p id="p0045">Based on the method of evidence-based pharmacy, PubMed, Embase, Cochrane library and Chinese database were retrieved systematically on March 25, and clinical guidance from Chinese, American, WHO authorties were searched manually. Advances in therapeutical drugs for COVID-19 were analyzed and evaluated, and were summarized in 
 <xref rid="tbl1" ref-type="table">Table 1</xref> . In addition, the American Sosiety of Health-System Pharmacist (ASHP) provided an evidence table for COVID-19-related treatment to help practitioners better understand current treatment options.
 <xref rid="bib12" ref-type="bibr">
  <sup>12</sup>
 </xref> Based on these available evidence, hospital pharmacists should help to formulate medication regimens for hospitalized patients with COVID-19 after fully balacing clinical benefits and the risk of medications.
</p>
